Quantum Biopharma Ltd. - Common Stock (QNTM)

CUSIP: 74764Y205

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock
Shares outstanding
3,834,204
Total 13F shares
128,326
Share change
+60,514
Total reported value
$936,794
Price per share
$7.30
Number of holders
22
Value change
+$435,810
Number of buys
11
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 74764Y205?
CUSIP 74764Y205 identifies QNTM - Quantum Biopharma Ltd. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Quantum Biopharma Ltd. - Common Stock (QNTM) as of Q4 2025

As of 31 Dec 2025, Quantum Biopharma Ltd. - Common Stock (QNTM) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 128,326 shares. The largest 10 holders included AdvisorShares Investments LLC, CITADEL ADVISORS LLC, Marex Group plc, GTS SECURITIES LLC, JANE STREET GROUP, LLC, Virtu Financial LLC, OSAIC HOLDINGS, INC., Steward Partners Investment Advisory, LLC, UBS Group AG, and TUCKER ASSET MANAGEMENT LLC. This page lists 22 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.